Clinical trials
Terminated Intermittent Claudication trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ARCA Biopharma, Inc. | 1 |
| Arkansas Heart Hospital | 1 |
| Genovate Biotechnology Co., Ltd., | 1 |
| Medtronic Endovascular | 1 |
| Novartis Pharmaceuticals | 1 |
| The Cleveland Clinic | 1 |
| University of Pennsylvania | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intermittent Claudication | 8 |
| Peripheral Arterial Disease | 6 |
| Peripheral Vascular Diseases | 2 |
| Arterial Occlusive Diseases | 1 |
| Chronic Limb-Threatening Ischemia | 1 |
| Embolism | 1 |
| Signs and Symptoms | 1 |
| Thromboembolism | 1 |
| Thrombosis | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.